Gauger Stine J, Palmelund Line B, Tian Yongsong, Marek Aleš, Namini Mathias R, Griem-Krey Nane, Petersen Madeline Y, Kickinger Stefanie, Mortensen Jonas S, Frølund Bente, Wellendorph Petrine
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark; Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Prague, Czech Republic.
J Biol Chem. 2025 Apr 24;301(6):108543. doi: 10.1016/j.jbc.2025.108543.
The Ca/CaM-dependent protein kinase II alpha (CaMKIIα) is a highly important synaptic protein, which comprises a unique holoenzyme structure organized via the central hub domain. Recently, a distinct binding pocket in the CaMKIIα hub domain was identified for the endogenous neuromodulator γ-hydroxybutyric acid (GHB) and related synthetic analogs. Intriguingly, of the four native CaMKII isozymes, only CaMKIIα accommodates GHB ligands. Key interacting residues in CaMKIIα were revealed, but their involvement in selectivity toward the alpha variant of CaMKII has remained unresolved. Aimed at elucidating the molecular determinants for this selectivity, we here conducted binding studies to CaMKII-HEK whole-cell homogenates using two different in-house-developed GHB-related radioligands, 3-hydroxycyclopent-1-enecarboxylic acid ([H]HOCPCA) and [H]O-5-hydroxydiclofenac, in combination with site-directed mutagenesis. Binding to CaMKIIα with the smaller type radioligand [H]HOCPCA validated key involvement of the four known residues (His395, Arg433, Arg453, and Arg469), but also revealed a role for the upper hub flexible loop containing the CaMKIIα-specific residue Trp403 (Leu in all other CaMKII isozymes) previously suggested to be involved in holoenzyme stability. Insertion of the corresponding residues (L467W/C533R) into CaMKIIβ failed to induce [H]HOCPCA binding. However, with the larger type radioligand, [H]O-5-hydroxydiclofenac, specific binding in CaMKIIβ (L467W/C533R) was achieved. Thus, the study confirms involvement of central binding residues and identifies the CaMKIIα flexible pocket loop as a distantly located allosteric factor in determining selectivity of GHB analogs for CaMKIIα. It sheds light on a remarkable interplay of the entire hub cavity for accommodation of ligands and corroborates GHB analogs as CaMKIIα-selective.
钙/钙调蛋白依赖性蛋白激酶IIα(CaMKIIα)是一种极其重要的突触蛋白,它通过中央枢纽结构域构成独特的全酶结构。最近,在CaMKIIα枢纽结构域中发现了一个独特的结合口袋,用于内源性神经调节剂γ-羟基丁酸(GHB)及其相关合成类似物。有趣的是,在四种天然CaMKII同工酶中,只有CaMKIIα能容纳GHB配体。已揭示了CaMKIIα中的关键相互作用残基,但它们对CaMKIIα变体的选择性参与仍未得到解决。为了阐明这种选择性的分子决定因素,我们在这里使用两种不同的内部开发的GHB相关放射性配体3-羟基环戊-1-烯羧酸([H]HOCPCA)和[H]O-5-羟基双氯芬酸,结合定点诱变,对CaMKII-HEK全细胞匀浆进行了结合研究。用较小类型的放射性配体[H]HOCPCA与CaMKIIα结合验证了四个已知残基(His395、Arg433、Arg453和Arg469)的关键参与,但也揭示了包含CaMKIIα特异性残基Trp403(在所有其他CaMKII同工酶中为Leu)的上部枢纽柔性环在先前认为参与全酶稳定性中的作用。将相应残基(L467W/C533R)插入CaMKIIβ未能诱导[H]HOCPCA结合。然而,使用较大类型的放射性配体[H]O-5-羟基双氯芬酸,在CaMKIIβ(L467W/C533R)中实现了特异性结合。因此,该研究证实了中央结合残基的参与,并确定CaMKIIα柔性口袋环是决定GHB类似物对CaMKIIα选择性的远距离变构因子。它揭示了整个枢纽腔在容纳配体方面的显著相互作用,并证实了GHB类似物对CaMKIIα的选择性。